Editorial: Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens
Payam Behzadi, Cecilia Ambrosi, Daniela Scribano, Stefania Zanetti, Meysam Sarshar, Márió Gajdács, Matthew Gavino Donadu
Abstract
Pseudomonas aeruginosa is a member of Pseudomonatoda (synonym Proteobacteria) phylum, belonging to the group of non-fermenting Gram-negative bacteria (NFGNB) Members of the NFGNB are similar in that they are not able to use fermentative biochemical processes to provide to their biological fuel from sugars for vital activities Currently, the Pseudomonas genus contains 299 different species (https://lpsn.dsmz.de/genus/pseudomonas). Among them, P. aeruginosa has a considerable capability for adapting to many different environments through the accessibility to a wide range of metabolic pathways. Furthermore, the presence of numerous virulence factors in its arsenal-owing to its high genetic plasticity-enforces the pathogenicity of P. aeruginosa The recognition of a versatile range of resistance mechanisms in these motile and non-fastidious bacteria has made it a great concern for healthcare institutions worldwide,